HLRCC Foundation

Knowledge Saves

  • Home
  • About Us
    • HLRCC Foundation
    • VHL UK/Ireland Charity Homepage
    • Driven to Cure
    • Contact Us
    • Medical, Research and Support Council
    • Privacy Policy
    • Disclaimer
  • Information
    • HLRCC Videos
    • HLRCC Quick Facts
    • HLRCC Brochure
    • HLRCC Handbook
    • Sample Family Letter
    • Clinical Care Centers
    • Science and Research
      • Science on HLRCC
      • Clinical Trials
      • Tissue Bank
      • MyVHL: Patient Natural History Study
  • News
  • Join Us
    • Facebook
    • Twitter
    • Register with us
    • MyVHL: Patient Natural History Study
  • Donate

Advertising a new HLRCC Clinical Phase II Trial

30th May 2021 By Graham

Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer

Last Updated on 30th May 2021 by Graham

Filed Under: Uncategorised

VHL Alliance is a NORD member organization

Last modified: 5th February 2026 @ 2:38 pm
  • Home
  • HLRCC Foundation
  • HLRCC Quick Facts
  • News
  • Donate
  • Join Us

Copyright © 2026 · Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Alliance